Dr. Basik’s laboratory is part of the Montreal Centre for Experimental Therapeutics in Cancer, located at the Jewish General Hospital/Segal Cancer Center and thus part of the Lady Davis Institute for Medical Research.  The laboratory focuses on the elucidation of mechanisms of drug resistance, the identification of novel therapeutic targets and the discovery and validation of genomic and proteomic biomarkers for the diagnosis, prognosis and prediction of response to treatment in breast and colon cancer.